Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-002072-15Phase 3Terminated
Phase 3 trial of arginine and acetylcysteine in coronary arteriosclerosis and type 2 diabetes mellitus (T2DM), sponsored by AOU Città della Salute e della Scienza di Torino. Started Jul 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-002072-15.